CVE-2023-3853
CVE-2023-3853 is a low-severity vulnerability in Phpscriptpoint Bloodbank with a CVSS 3.x base score of 3.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.
Key facts
- Severity: Low (CVSS 3.x base score 3.5)
- CVSS v2: 4.0
- EPSS exploit prediction: 0% (24th percentile)
- Actively exploited: Not listed in CISA KEV
- Weakness: CWE-79
- Affected product: Phpscriptpoint Bloodbank
- Published:
- Last modified:
Description
A vulnerability was found in phpscriptpoint BloodBank 1.1. It has been rated as problematic. This issue affects some unknown processing of the file page.php. The manipulation leads to cross site scripting. The attack may be initiated remotely. The identifier VDB-235205 was assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.
Frequently asked questions
- What is CVE-2023-3853?
- A vulnerability was found in phpscriptpoint BloodBank 1.1. It has been rated as problematic. This issue affects some unknown processing of the file page.php. The manipulation leads to cross site scripting. The attack may be initiated remotely. The identifier VDB-235205 was assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.
- How severe is CVE-2023-3853?
- CVE-2023-3853 has a CVSS 3.x base score of 3.5, rated low severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is none, integrity low, and availability none.
- Is CVE-2023-3853 being actively exploited?
- It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (24th percentile), an estimate of the probability of exploitation in the next 30 days.
- What products are affected by CVE-2023-3853?
- CVE-2023-3853 affects Phpscriptpoint Bloodbank. See the affected-products list for the exact vulnerable versions.
- How do I fix CVE-2023-3853?
- Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
- When was CVE-2023-3853 published?
- CVE-2023-3853 was published on 2023-07-23 and last updated on 2026-06-17.
References
Affected products (1)
- cpe:2.3:a:phpscriptpoint:bloodbank:1.1:*:*:*:*:*:*:*
More vulnerabilities in Phpscriptpoint Bloodbank
- CVE-2023-3854 — Medium (CVSS 6.3): A vulnerability classified as critical has been found in phpscriptpoint BloodBank 1.1. Affected is an unknown function…
All CVEs affecting Phpscriptpoint Bloodbank →
Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities
- CVE-2025-49410 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Imran Emu TC…
- CVE-2024-47875 — Critical (CVSS 10.0): DOMPurify is a DOM-only, super-fast, uber-tolerant XSS sanitizer for HTML, MathML and SVG. DOMpurify was vulnerable to…
- CVE-2024-6886 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Gitea…
- CVE-2023-45144 — Critical (CVSS 10.0): com.xwiki.identity-oauth:identity-oauth-ui is a package to aid in building identity and service providers based on…
- CVE-2023-45138 — Critical (CVSS 10.0): Change Request is an pplication allowing users to request changes on a wiki without publishing the changes directly.…
- CVE-2022-4361 — Critical (CVSS 10.0): Keycloak, an open-source identity and access management solution, has a cross-site scripting (XSS) vulnerability in the…
Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →